Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Mini oral session - Supportive and palliative care

1593MO - Combined early palliative care in patients with non small cell lung cancer: A randomised controlled trial in Chongqing, China

Date

21 Oct 2023

Session

Mini oral session - Supportive and palliative care

Topics

Supportive Care and Symptom Management;  Nutritional Support;  Therapy

Tumour Site

Non-Small Cell Lung Cancer

Presenters

Mengting Chen

Citation

Annals of Oncology (2023) 34 (suppl_2): S887-S894. 10.1016/S0923-7534(23)01267-X

Authors

M. Chen1, H. Yu2

Author affiliations

  • 1 Clinical Nutrition, Chongqing Cancer Hospital, 400000 - Chongqing/CN
  • 2 Department Of Geriatric Oncology And Department Of Palliative Care, Chongqing Cancer Hospital, 400000 - Chongqing/CN

Resources

This content is available to ESMO members and event participants.

Abstract 1593MO

Background

Effective interventions to improve prognosis in non-small-cell lung cancer (NSCLC) are urgently needed. We assessed the effect of the early integration of interdisciplinary palliative care (based on Ewarm model) for patients with NSCLC on the quality of life (QoL), psychological state, cancer pain and nutritional status.

Methods

In this randomised controlled trial, 280 newly diagnosed NSCLC patients were enrolled and randomly assigned (1:1) to the combined early palliative care (CEPC) group integrated with standard oncologic care or standard oncological care (SC) group. QoL and psychological state were assessed at baseline and at 24 weeks by Functional Assessment of Cancer Therapy-Lung (FACT-L) scale, the Hospital Anxiety and Depression Scale (HADS) and Patient Health Questionnaire-9 (PHQ-9), respectively. Cancer nutritional and pain status were assessed with the use of the Patient-Generated Subjective Global Assessment (PG-SGA) and Numerical Rating Scale (NRS), respectively. The primary end point was overall survival (OS). The second end point was the change in the quality of life, psychological state, pain and nutritional status at 24 weeks. Analysis was by intention to treat.

Results

280 patients were enrolled: 140 in CEPC group (102 completed) and 140 in the SC group (82 completed). CEPC group had a better QoL than SC group (all P < 0.05). In addition, fewer patients in the CEPC group than in the SC group had depressive (P < 0.05) symptoms. Furthermore, patients in CEPC group had a better nutritional status and pain than SC group (P =0.007 and P =0.003). Patients in the CEPC group had significantly longer survival than those in the SC group (median OS, 24.6 vs. 20.4 months; P=0.042) (HR, 0.19; 95% CI, 0.04 to 0.85; P=0.029).

Conclusions

Among patients with non-small-cell lung cancer, early palliative care led to significant improvements in longer survival, quality of life, psychological state, pain and nutritional status.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

Has not received any funding.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.